Your email has been successfully added to our mailing list.

×
-0.000144450222453211 0.000144450222453375 -0.000231120355925302 -0.000491130756341247 -0.00303345467152006 -0.00546021840873631 -0.00202230311434676 -0.00482463742994152
Stock impact report

ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline [Yahoo! Finance]

AbbVie Inc. (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
Company Research Source: Yahoo! Finance
The impending acquisition will add Nimble's lead preclinical asset and a pipeline of other novel oral peptide candidates with potential across several autoimmune diseases to AbbiVie's Immunology pipeline. The acquisition also allows AbbVie to utilize Nimble's proprietary peptide synthesis platform to enable the discovery and optimization of oral peptide therapeutics. Nimble's lead preclinical asset is an investigational oral peptide IL23R inhibitor in preclinical development for the treatment of psoriasis and inflammatory bowel disease (IBD). Per AbbVie, IL23R is a validated therapeutic target in certain autoimmune diseases, significantly contributing to psoriasis and IBD by driving inflammation and enhancing immune responses. In the past three months, shares of AbbVie have lost 10.4% compared with the industry's 14.4% decline. Zacks Investment Research Image Source: Zacks Investment Research More on ABBV's Strategic Acquisition of Nimble The acquisition of Nimble Therapeu Show less Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ABBV alerts
Opt-in for
ABBV alerts

from News Quantified
Opt-in for
ABBV alerts

from News Quantified